Related Experiment Video

Updated: Aug 23, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

Autoimmunity in chagas disease cardiomyopathy: Fulfilling the criteria at last?

J Kalil1, E Cunha-Neto

  • 1Transplantation Immunology Laboratory, Instituto do Coração Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

Parasitology Today (Personal Ed.)
|October 1, 1996
PubMed

Insights

This review examines evidence linking autoimmunity to chronic Chagas cardiomyopathy (CCC). It explores molecular antigens and immune mechanisms, discussing criteria for classifying CCC as an autoimmune disease.

Area of Science:

  • Cardiology
  • Immunology
  • Infectious Diseases

Background:

  • Chronic Chagas cardiomyopathy (CCC) is a significant health concern.
  • The role of autoimmunity in CCC pathogenesis remains under investigation.

Purpose of the Study:

  • To review current evidence for autoimmunity in CCC.
  • To discuss molecular antigens and immunopathological mechanisms involved.
  • To evaluate criteria for classifying CCC as an organ-specific autoimmune disease.

Main Methods:

  • Literature review of recent studies on Chagas disease and autoimmunity.
  • Analysis of immunopathological mechanisms and molecularly defined antigens.
  • Discussion of diagnostic and classification criteria for CCC.

Main Results:

  • Growing evidence supports an autoimmune component in CCC.
  • Specific molecular antigens and immune pathways are implicated in CCC development.
  • Criteria for defining CCC as an autoimmune disease are being refined.

Conclusions:

  • Autoimmunity plays a crucial role in the development and progression of chronic Chagas cardiomyopathy.
  • Further research is needed to fully elucidate the autoimmune mechanisms driving CCC.
  • Establishing clear criteria for CCC as an autoimmune disease is essential for targeted therapies.

More Related Videos

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...